SITE012-0213

SITE012 (BRA) › SITE012-0213

SITE012-0213

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-05-10

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-08 (study day 55); relationship: not assessed

mild assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-12-19 (study day 35); relationship: not assessed

mild assessed

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-12-16 (study day 32); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.